Camylofin
From Wikipedia, the free encyclopedia
 |
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
(Learn how and when to remove this template message)
|
 |
|
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | A03AA03 (WHO) |
| Identifiers | |
|
|
| CAS Number | 54-30-8  |
| PubChem (CID) | 5902 |
| ChemSpider | 5691  |
| UNII | 340B6Q764V |
| ChEMBL | CHEMBL253592 |
| ECHA InfoCard | 100.000.184 |
| Chemical and physical data | |
| Formula | C19H32N2O2 |
| Molar mass | 320.47 g/mol |
| 3D model (Jmol) | Interactive image |
|
|
|
|
| (what is this?) (verify) |
|
Camylofin is an antimuscarinic.
Camylofin is a smooth muscle relaxant with both anticholinergic action as well as direct smooth muscle action. Anticholinergic action is produced by inhibiting the binding of acetylcholine to muscarinic receptors, but the action is less pronounced. Direct smooth muscle relaxation is achieved by inhibiting phosphodiesterase type IV, which leads to increased cyclic AMP and eventually reduced cytosolic calcium. Thus camylofin has a comprehensive action to relieve smooth muscle spasm. It is used to treat stomach ache in infants and children. Usually it is given in combination with paracetamol to treat stomach ache, as well as pyrexia.
 |
This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
